Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-032218
Filing Date
2011-05-25
Accepted
2011-05-24 18:05:04
Documents
12
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT v218209_10k.htm 10-K 2853666
2 5-YEAR COLLABORATION AGREEMENT WITH JAIVA TECHNOLOGIES INC. v218209_ex10-64.htm EX-10.64 67451
3 5-YEAR DISTRIBUTION AGREEMENT WITH GUAR DIAGNO NEW DEHLI v218209_ex10-65.htm EX-10.65 145432
4 GRAPHIC logo.jpg GRAPHIC 37068
5 2-YEAR DISTRIBUTION AGREEMENT WITH NAROO DITECH INC. v218209_ex10-66.htm EX-10.66 137564
6 GRAPHIC logo2.jpg GRAPHIC 27898
7 GRAPHIC logo3.jpg GRAPHIC 16270
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 v218209_ex31-1.htm EX-31.1 14608
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 v218209_ex31-2.htm EX-31.2 14474
10 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 v218209_ex32-1.htm EX-32.1 9419
11 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 v218209_ex32-2.htm EX-32.2 8530
13 GRAPHIC corresp-logo.jpg GRAPHIC 5909
  Complete submission text file 0001144204-11-032218.txt   3372955
Mailing Address 2492 WALNUT AVENUE STE 100 TUSTIN CA 92780
Business Address 2492 WALNUT AVENUE STE 100 TUSTIN CA 92780 7145054460
RADIENT PHARMACEUTICALS Corp (Filer) CIK: 0000838879 (see all company filings)

EIN.: 330413161 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-16695 | Film No.: 11869034
SIC: 2834 Pharmaceutical Preparations